Amarin Corp Plc (AMRN)

[CalMustang]

I disagree.

Recall that Hikma is arguing that their Rx would last for 12 weeks or less, after which the patient would be off of it. You don't get a $750MM market with a hypertriglyceridemia population of 4 million people that are only going to take your drug for 2-3 months. Especially when most analysts are considering the R-IT market to be "only" around $2-4B in the US.